https://www.nature.com/articles/d41573-022-00191-2
Recently retired head of vaccine R&D at Pfizer, Kathrin Jansen, discusses the lightning speed development of SARS-CoV-2 vaccines — and the implications for vaccine platforms.
Create an account or login to join the discussion